Literature DB >> 6830688

Characterization of human colon carcinoma cell lines isolated from a single primary tumour.

M G Brattain, M E Marks, J McCombs, W Finely, D E Brattain.   

Abstract

The initiation of a cultured human colon carcinoma line on a feeder layer of confluent fibroblasts is described. Attempts to initiate cultures without fibroblast feeder layers were not successful. Two sub-lines (designated HCT C and HCT C Col) were isolated and weaned from cells growing on the surface of the feeder layer. The sub-lines had different morphologies, secreted different levels of carcinoembryonic antigen (CEA) into the medium of confluent cultures and had slightly different karyotypes. Both sub-lines grew in semi-solid medium and formed xenografts when injected s.c. into athymic nude mice. Analysis of radioiodinated cell membrane components indicated small, but significant differences between the sub-lines.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6830688      PMCID: PMC2011309          DOI: 10.1038/bjc.1983.56

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  A comparison of methods for the isolation of carcinoembryonic antigen.

Authors:  P M Kimball; M G Brattain
Journal:  Cancer Res       Date:  1978-03       Impact factor: 12.701

2.  Clinical and pharmacological implications of cancer cell differentiation and heterogeneity.

Authors:  P Calabresi; D L Dexter; G H Heppner
Journal:  Biochem Pharmacol       Date:  1979-06-15       Impact factor: 5.858

3.  The use of proteolytic enzymes for the mapping of structural rearrangements in the chromosomes of man.

Authors:  M Seabright
Journal:  Chromosoma       Date:  1972       Impact factor: 4.316

4.  Feeder layer and nutritional requirements for the establishment and cloning of human malignant lymphoma cell lines.

Authors:  A L Epstein; H S Kaplan
Journal:  Cancer Res       Date:  1979-05       Impact factor: 12.701

Review 5.  Tumor heterogeneity and the biology of cancer invasion and metastasis.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1978-09       Impact factor: 12.701

6.  Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor.

Authors:  G H Heppner; D L Dexter; T DeNucci; F R Miller; P Calabresi
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

7.  N,N-dimethylformamide-induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells.

Authors:  D L Dexter; J A Barbosa; P Calabresi
Journal:  Cancer Res       Date:  1979-03       Impact factor: 12.701

8.  Isoenzymes of beta-hexosaminidase from normal rat colon and colonic carcinoma.

Authors:  M G Brattain; C Green; P M Kimball; M Marks; M Khaled
Journal:  Cancer Res       Date:  1979-10       Impact factor: 12.701

Review 9.  High-resolution chromosome analysis in clinical medicine.

Authors:  J J Yunis; M E Chandler
Journal:  Prog Clin Pathol       Date:  1978

10.  Partial purification of human colonic carcinoma cells by sedimentation.

Authors:  M G Brattain; P M Kimball; T G Pretlow; A M Pitts
Journal:  Br J Cancer       Date:  1977-06       Impact factor: 7.640

View more
  16 in total

1.  Do aggressive subclones within primary colorectal cancer give rise to liver metastases?

Authors:  J R Jass; K Mukawa; P I Richman; P A Hall
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

2.  Co-inoculation of human and murine carcinoma cells induces reciprocal suppression of metastasis by both cell lines.

Authors:  S M Nielsen-Preiss; J P Quigley; J E Testa
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

Review 3.  Heterogeneity of human colon carcinoma.

Authors:  M G Brattain; A E Levine; S Chakrabarty; L C Yeoman; J K Willson; B Long
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

4.  Ezrin expression and cell survival regulation in colorectal cancer.

Authors:  Premila D Leiphrakpam; Ashwani Rajput; Michelle Mathiesen; Ekta Agarwal; Audrey J Lazenby; Chandrakanth Are; Michael G Brattain; Sanjib Chowdhury
Journal:  Cell Signal       Date:  2014-01-22       Impact factor: 4.315

Review 5.  Orthotopic implantation of human colon carcinomas into nude mice provides a valuable model for the biology and therapy of metastasis.

Authors:  I J Fidler
Journal:  Cancer Metastasis Rev       Date:  1991-10       Impact factor: 9.264

6.  Heterogeneity in antigenic expression and radiosensitivity in human colon carcinoma cell lines.

Authors:  G Frykholm; B Glimelius; S Richter; J Carlsson
Journal:  In Vitro Cell Dev Biol       Date:  1991-12

7.  Establishment and characterization of a human colon cancer cell line, OUMS-23, from a patient with familial adenomatous polyposis.

Authors:  M Miyazaki; S Tsuboi; K Mihara; T Kosaka; K Fukaya; K Kino; M Mori; M Namba
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

8.  Prognostic and therapeutic implications of NHERF1 expression and regulation in colorectal cancer.

Authors:  Premila D Leiphrakpam; Audrey J Lazenby; Sanjib Chowdhury; Lynette M Smith; Michelle Mathiesen; Michael G Brattain; Jing Wang; Jennifer D Black; Chandrakanth Are
Journal:  J Surg Oncol       Date:  2019-12-22       Impact factor: 3.454

9.  Intra-tumoral heterogeneity in metastatic potential and survival signaling between iso-clonal HCT116 and HCT116b human colon carcinoma cell lines.

Authors:  Sanjib Chowdhury; Melanie Ongchin; Elizabeth Sharratt; Ivan Dominguez; Jing Wang; Michael G Brattain; Ashwani Rajput
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

10.  Activation of MEK1 or MEK2 isoform is sufficient to fully transform intestinal epithelial cells and induce the formation of metastatic tumors.

Authors:  Laure Voisin; Catherine Julien; Stéphanie Duhamel; Kailesh Gopalbhai; Isabelle Claveau; Marc K Saba-El-Leil; Ian Gaël Rodrigue-Gervais; Louis Gaboury; Daniel Lamarre; Mark Basik; Sylvain Meloche
Journal:  BMC Cancer       Date:  2008-11-17       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.